Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Project Updates and Milestones news
17 February 2026
FDA Approves Johnson & Johnson's Monthly EGFR Therapy RYBREVANT FASPRO
FDA approves monthly dosing for RYBREVANT FASPRO, maintaining efficacy and reducing administration time and reactions compared to bi-weekly and IV schedules for EGFR-mutated NSCLC treatment.
17 February 2026
ElevenEs Secures Series B Funding with Caterpillar Venture Capital
ElevenEs to start building a 1GWh LFP battery factory in Serbia, aiming for 2027 deliveries, creating 350 jobs, and advancing European battery tech.
17 February 2026
Neste and World Fuel Services Expand SAF Availability at 100+ European Airports
The five-year agreement supports regulatory compliance and boosts SAF supply, leveraging World Fuel's network and Neste's production capabilities.
17 February 2026
ORLEN's Largest Investment Program
PLN 380 billion will modernize Poland's energy system, focusing on gas security, renewables, and grid expansion, ensuring secure, affordable energy.
17 February 2026
Worley Advises on New Zealand LNG Terminal
Worley provides technical support for New Zealand's LNG terminal, ensuring international standards and local compliance, from procurement to commissioning.
16 February 2026
Lilly's Retevmo Shows Event-Free Survival Benefit in Early-Stage RET Fusion-Positive Lung Cancer
Selpercatinib significantly reduces disease recurrence risk in early-stage RET fusion-positive NSCLC. Safety profile aligns with previous trials. Detailed results pending.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
16 February 2026
Eni Discovers Gas and Condensate in Côte d'Ivoire's Calao Channel
Murene South-1X well in Block CI-501 confirms significant gas and condensate potential in Côte d'Ivoire, with estimated volumes of 5.0 Tcf gas and 450 million barrels of condensate.
16 February 2026
Chevron Secures Four Offshore Leases for Greek Exploration
Chevron and HELLENiQ ENERGY sign agreements for offshore exploration in Greece, focusing on seismic work to assess hydrocarbon potential. Awaiting Greek Parliament ratification.
16 February 2026
Roche Reports Positive Phase III Results for Gazyva in Membranous Nephropathy
Phase III study shows Gazyva achieves higher remission rates in membranous nephropathy, with safety consistent and no new signals. Data to be shared with health authorities.
15 February 2026
Genentech's Gazyva Shows Positive Phase III Results in Primary Membranous Nephropathy
Phase III study shows Gazyva achieves significant remission in primary membranous nephropathy, with safety profile consistent and no new signals. Data to be shared with health authorities.
14 February 2026
Eni Announces Major Oil Find in Angola's Algaita-01
The Algaita-01 well in Block 15/06, offshore Angola, reveals 500 million barrels of oil, with existing infrastructure boosting development potential.
13 February 2026
SkyNRG Begins Construction of First SAF Plant in the Netherlands
The plant will produce 100,000 tonnes of SAF annually, cutting GHG emissions by up to 90%. KLM is the main off-taker. Construction follows a seven-year development phase. Completion is due in 2028.
13 February 2026
ASPİLSAN Enerji Hosts SAFELOOP Project Meeting in Kayseri
The SAFELOOP Project focuses on enhancing battery sustainability and recycling, uniting 15 organizations to improve lithium-ion battery safety and performance.
13 February 2026
Sinopec's Natural Gas Power Project Connects to Grid
Sinopec's project uses natural gas pressure differences for power, generating over 10,000 kWh by Feb 12, reducing costs and enhancing energy efficiency with intelligent control systems.
13 February 2026
Elkem Q4 2025: Market Challenges Offset by Cost Improvements; Silicones Division Sale
EBITDA fell 24% YoY. Silicones sale to Bluestar boosts focus and flexibility. Safety incident in Lyon. Market uncertainties persist, but strong cost positions aid adaptation.
12 February 2026
SkyNRG Begins Construction of Delfzijl SAF Plant
The plant will produce 100,000 tonnes of SAF annually, cutting GHG emissions by up to 90%. KLM is the main off-taker. Construction starts after securing non-recourse project financing.
12 February 2026
Eni, YPF, XRG Advance Argentina LNG Project
The agreement advances a 12 mtpa LNG project in Argentina, initiating FEED and aiming for a final investment decision by late 2026.
12 February 2026
Merck Presents New Data on Bladder and Kidney Cancer Treatments at 2026 ASCO GU Symposium
New data shows improved survival rates for bladder and kidney cancer treatments, highlighting advancements in Merck's oncology portfolio at the ASCO GU Symposium.
12 February 2026
Kemira 2025 Financial Results: Strong Profitability Amid Weak Market
Revenue and EBITDA declined due to market softness. Strategic acquisitions and cost efficiency measures were implemented. Dividend increase and share buyback program proposed.
12 February 2026
Sinopec Phenol Debuts in International Market
Sinopec's phenol export to New Zealand marks its international debut, achieved through strategic market analysis, efficient coordination, and meeting customer specifications.
12 February 2026
ORLEN Aviation Expands to Prague Market
ORLEN Aviation secures a license to refuel aircraft at Prague Airport, marking its first international operational contract, starting Q2 2026.
11 February 2026
Fluor to Expand Centrus' Uranium Enrichment Plant in Ohio
Fluor will lead engineering, procurement, and construction for Centrus' Ohio plant expansion, boosting LEU and HALEU production and creating over 1,300 jobs.
11 February 2026
Terumo Europe's Heverlee Site Named Factory of the Future Again
The Heverlee site earns the Factory of the Future title for 2026–2028, highlighting its focus on innovation, sustainability, and quality in healthcare manufacturing.
11 February 2026
ORLEN Acquires 25% Stake in Afrodite Gas Discovery
ORLEN acquires 25% of PL293 in the North Sea, targeting 1.9 bcm of gas. The project tests new production methods and aligns with ORLEN's strategy for Norwegian gas development by 2030.
10 February 2026
RWE's Nordseecluster Offshore Wind Substations Ready for Installation
Two offshore substations completed in France will be installed in the German North Sea, advancing the Nordseecluster wind project, which will power 1.6 million homes.
10 February 2026
ORLEN Expands LNG Operations: Increased Deliveries, Fleet, and Import Capacity
In 2025, LNG imports to Poland rose by 30%, with expanded terminal capacity and fleet. New export markets included Japan and Turkey. A second terminal will further boost capacity.
10 February 2026
Borealis and Partners Launch Circular Waste Management in Indonesia
A feasibility study will assess creating a plastics recycling facility in East Java, aiming to transform waste into high-quality recycled polyolefins and promote a circular economy.
10 February 2026
RWE Secures UK Contracts for 290 MW Solar and Wind Capacity
RWE wins Contracts for Difference for 215 MW solar and 76 MW wind in UK, powering 240,000 homes annually. Prices set at £65.23/MWh for solar and £72.24/MWh for wind.
10 February 2026
FDA Grants Priority Review to Takeda's Oveporexton for Narcolepsy Type 1
Oveporexton, an orexin agonist, aims to treat narcolepsy type 1 by restoring orexin signaling. FDA's decision expected in Q3. Current treatments insufficient for many patients.
10 February 2026
Worley Partners with Samsung C&T for CO₂ Sequestration in Qatar
Worley to provide engineering for Qatar's LNG CO₂ sequestration, storing 4.3 million metric tonnes annually, supporting sustainable development and energy transition.
Next →
